Amarin and FDA Reaffirm Concurrence on REDUCE-IT Through Special Protocol Assessment Agreement Amendment Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin and FDA Reaffirm Concurrence on REDUCE-IT Through Special Protocol Assessment Agreement Amendment
Amarin Appoints Craig B. Granowitz Chief Medical Officer and Names Steven Ketchum Chief Scientific Officer Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Appoints Craig B. Granowitz Chief Medical Officer and Names Steven Ketchum Chief Scientific Officer
Request for Continued Stay in Court Proceedings Submitted in Amarin First Amendment Litigation Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Request for Continued Stay in Court Proceedings Submitted in Amarin First Amendment Litigation
Amarin to Report Fourth Quarter and Full-Year 2015 Results and Host Conference Call on February 25, 2016 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report Fourth Quarter and Full-Year 2015 Results and Host Conference Call on February 25, 2016
Amarin Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Update on Operations Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reports Fourth Quarter and Year-End 2015 Financial Results and Provides Update on Operations
Amarin's Right to Promote Vascepa(R) Off-Label Affirmed Under First Amendment Litigation Settlement Terms Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin's Right to Promote Vascepa(R) Off-Label Affirmed Under First Amendment Litigation Settlement Terms
Court Approves Proposed Settlement Terms in Amarin First Amendment Litigation Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Court Approves Proposed Settlement Terms in Amarin First Amendment Litigation
Amarin Reaches Target Enrollment in Cardiovascular Outcomes Study of Vascepa(R) in Patients With Elevated Triglycerides Despite Statin Therapy Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin Reaches Target Enrollment in Cardiovascular Outcomes Study of Vascepa(R) in Patients With Elevated Triglycerides Despite Statin Therapy
New Clinical and Pre-Clinical Data Presented at American College of Cardiology Meeting on the Effect of EPA Therapy in Statin-Treated Patients and on Endothelial Function in Exploratory Studies Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about New Clinical and Pre-Clinical Data Presented at American College of Cardiology Meeting on the Effect of EPA Therapy in Statin-Treated Patients and on Endothelial Function in Exploratory Studies
Amarin to Report First Quarter 2016 Results and Host Conference Call on May 5, 2016 Submitted by amarin on Fri, 12/08/2017 - 04:49 Home Read more about Amarin to Report First Quarter 2016 Results and Host Conference Call on May 5, 2016
